C12Y 207/04003
Adenylate kinase
Official title: Adenylate kinase (2.7.4.3)
C12Y207/04003 (Adenylate kinase) appears on 16 US grants and 35 published applications in this corpus.
Search patents in C12Y- Granted patents
- 16
- Published applications
- 35
- Assignees
- 23
- Inventors
- 107
- Latest grant
- 8 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 5 |
| 2017 | 0 | 3 |
| 2018 | 1 | 1 |
| 2019 | 1 | 3 |
| 2020 | 4 | 3 |
| 2021 | 0 | 2 |
| 2022 | 2 | 4 |
| 2023 | 1 | 2 |
| 2024 | 2 | 5 |
| 2025 | 1 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Production method of enzymatic reaction using adenosine instead of ATP8 Jul 2025US 12,351,848 B2Anhui Gsh Bio-Tech Co., Ltd.
- Production method of enzymatic reaction using adenosine instead of ATP26 Mar 2024US 11,939,615 B2Anhui Gsh Bio-Tech Co., Ltd.
- Engineered adenylate kinase variant enzymes27 Feb 2024US 11,913,037 B2Codexis, Inc.
- Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis31 Oct 2023US 11,801,227 B2ModernaTX, Inc.
- Rapid approach for detection of bacterial spores23 Aug 2022US 11,421,260 B2Ecolab USA Inc.
- Cell-free ppi-driven atp regeneration platform9 Apr 2026US 2026/0098284 A1
- Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof12 Mar 2026US 2026/0069656 A1
- Production of psychedelic compounds29 May 2025US 2025/0171815 A1
- Engineered adenylate kinase variants17 Apr 2025US 2025/0122488 A1Codexis, Inc.
- Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis18 Jul 2024US 2024/0238210 A1Moderna TX, Inc.
Most cited
By later US patents
- Combined use of .beta.-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides130US 5,374,541 ACytel Corporation · 1994
- Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated39US 5,324,731 AAmira, Inc. · 1994
- Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent24US 5,676,978 AAmira, Inc. · 1997
- Creatine analogs having antiviral activity22US 5,321,030 AAmira, Inc. · 1994
- Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof19US 9,878,004 B2Axcella Health Inc. · 2018